State Sanctions & Medicaid Managed Care: What You Need to Know

The oversight of Medicaid managed care organizations (MCOs) is facing scrutiny, with new evidence suggesting that state-level sanctions don’t consistently lead to improvements in performance. A recent analysis indicates that roughly one in four sanctions imposed on these organizations aren’t effectively addressed, raising questions about the strength of both state and federal accountability measures. This has implications for the roughly 89 million Americans enrolled in Medicaid managed care programs, as consistent oversight is crucial for ensuring access to quality healthcare.

The Challenge of Consistent Oversight

The core issue isn’t a lack of sanctioning power, but rather inconsistent application and follow-through. States and the federal government have a range of tools at their disposal to hold MCOs accountable – from financial penalties to suspension or even termination of contracts. However, a report published by healthlaw.org in July 2025 revisited the use of these sanctions and found that many states utilize only a fraction of the available options. The study builds on earlier work from 2022, highlighting a persistent pattern of under-enforcement.

These sanctions are intended to address violations of various regulations, including California’s Medi-Cal laws, federal Medicaid guidelines, and the Knox-Keene Health Care Services Act of 1975. The California Department of Health Care Services (DHCS), for example, outlines a detailed process for imposing administrative and financial penalties on Medi-Cal managed care health plans that fall short of these standards.

What Types of Sanctions Are Used?

Sanctions can accept many forms. Financial penalties, or fines, are common, but their effectiveness is debated. Liquidated damages, a pre-determined monetary amount for specific violations, are also used. Administrative actions can include corrective action plans, mandated training for staff, or increased oversight from the state. More severe actions involve suspension or termination of an MCO’s contract, effectively removing them from the Medicaid program. The variability in how these are applied is a key concern.

Why Sanctions May Not Be Working as Intended

The recent findings, as reported by AJMC, point to a lack of standardization in how sanctions are reported and enforced. This inconsistency stems from a combination of factors. States may have different priorities, different levels of resources dedicated to oversight, and varying interpretations of what constitutes a serious violation. The federal Centers for Medicare & Medicaid Services (CMS) lacks consistent reporting and enforcement guidelines, creating a patchwork system of accountability.

The lack of remediation – the actual correction of the issues that led to the sanction – is particularly troubling. If a sanction doesn’t result in meaningful change, it loses its deterrent effect. This suggests that the current system may be more focused on identifying problems than on ensuring they are fixed. It’s important to note that the analysis doesn’t delve into the *reasons* for non-remediation; it could be due to the complexity of the issues, the MCO’s resistance to change, or insufficient state resources to enforce compliance.

Who is Affected by Inconsistent Sanctions?

The primary group affected by inconsistent Medicaid managed care sanctions are the 89 million Americans enrolled in these programs. These individuals rely on Medicaid for access to essential healthcare services, and the quality of that care is directly linked to the performance of the MCOs. When sanctions aren’t effective, it can lead to continued issues with access to care, quality of services, and administrative burdens for beneficiaries. This disproportionately impacts vulnerable populations, including low-income individuals, children, seniors, and people with disabilities.

Geographically, the impact varies depending on state policies and enforcement practices. States with more robust oversight systems are likely to notice better outcomes for their Medicaid beneficiaries. However, even within states, there can be significant variation in performance across different MCOs.

The Role of CMS and Future Steps

The findings underscore the need for greater federal leadership in standardizing Medicaid managed care oversight. CMS could play a crucial role in developing clear reporting guidelines, establishing consistent enforcement standards, and providing technical assistance to states. This would help to ensure that all MCOs are held to the same level of accountability, regardless of where they operate.

The healthlaw.org report suggests that states could also benefit from expanding their use of available sanctioning tools. This includes not only imposing financial penalties but also requiring MCOs to implement comprehensive corrective action plans and providing ongoing monitoring to ensure compliance.

What’s on the Horizon for Medicaid Accountability?

Several key processes are underway that could impact Medicaid managed care oversight. CMS is currently reviewing its regulations and guidance related to MCO accountability. States are also evaluating their own policies and practices in light of the recent findings. It’s likely that we will see increased scrutiny of MCO performance in the coming months and years, as policymakers seek to improve the quality and accessibility of Medicaid services. Further research is needed to understand the root causes of non-remediation and to identify effective strategies for improving MCO accountability.